Nothing Special   »   [go: up one dir, main page]

Konopka et al., 2009 - Google Patents

Human-specific transcriptional regulation of CNS development genes by FOXP2

Konopka et al., 2009

View HTML
Document ID
18079723528076477445
Author
Konopka G
Bomar J
Winden K
Coppola G
Jonsson Z
Gao F
Peng S
Preuss T
Wohlschlegel J
Geschwind D
Publication year
Publication venue
Nature

External Links

Snippet

The signalling pathways controlling both the evolution and development of language in the human brain remain unknown. So far, the transcription factor FOXP2 (forkhead box P2) is the only gene implicated in Mendelian forms of human speech and language dysfunction,,. It …
Continue reading at www.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Similar Documents

Publication Publication Date Title
Konopka et al. Human-specific transcriptional regulation of CNS development genes by FOXP2
Kim et al. Single-nucleus transcriptomics reveals functional compartmentalization in syncytial skeletal muscle cells
Jacko et al. Rbfox splicing factors promote neuronal maturation and axon initial segment assembly
Braun et al. Mutations in multiple components of the nuclear pore complex cause nephrotic syndrome
Doorenweerd et al. Timing and localization of human dystrophin isoform expression provide insights into the cognitive phenotype of Duchenne muscular dystrophy
Liu et al. Progressive degeneration of human neural stem cells caused by pathogenic LRRK2
Nakaya et al. Amyotrophic Lateral Sclerosis associated FUS mutation shortens mitochondria and induces neurotoxicity
Deriziotis et al. De novo TBR1 mutations in sporadic autism disrupt protein functions
Sowers et al. Disruption of the non-canonical Wnt gene PRICKLE2 leads to autism-like behaviors with evidence for hippocampal synaptic dysfunction
Boulting et al. Activity-dependent regulome of human GABAergic neurons reveals new patterns of gene regulation and neurological disease heritability
Barnard et al. Mutations and modeling of the chromatin remodeler CHD8 define an emerging autism etiology
Gauthier et al. De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia
Couthouis et al. A yeast functional screen predicts new candidate ALS disease genes
Liao et al. Molecular correlates of age-dependent seizures in an inherited neonatal-infantile epilepsy
Zhang et al. Dysregulation of synaptogenesis genes antecedes motor neuron pathology in spinal muscular atrophy
Arboleda et al. Mutations in the PCNA-binding domain of CDKN1C cause IMAGe syndrome
Wen et al. Synaptic dysregulation in a human iPS cell model of mental disorders
Chang et al. The schizophrenia risk gene ZNF804A: clinical associations, biological mechanisms and neuronal functions
Yu et al. Systems-level analysis of cell-specific AQP2 gene expression in renal collecting duct
Verma et al. Rbfox2 function in RNA metabolism is impaired in hypoplastic left heart syndrome patient hearts
Katsel et al. The expression of long noncoding RNA NEAT1 is reduced in schizophrenia and modulates oligodendrocytes transcription
Zhao et al. Quaking I controls a unique cytoplasmic pathway that regulates alternative splicing of myelin-associated glycoprotein
Cuttler et al. Emerging evidence implicating a role for neurexins in neurodegenerative and neuropsychiatric disorders
Goold et al. Down-regulation of the dopamine receptor D2 in mice lacking ataxin 1
Gray et al. Translational profiling of stress-induced neuroplasticity in the CA3 pyramidal neurons of BDNF Val66Met mice